Friday, August 10, 2018 Daily Archives

eBook: Biopharmaceutical Training – Train Your Team to Meet Evolving Industry Needs

by

Welcome to this year’s focus on industry training programs. In the past three years we’ve brought this information to you in several forms: as a full supplement issue (2016), a featured report (2017) – and now this ebook. Each program that we’ve profiled offers its unique approach to training present and future biotechnologists. The best of the programs offer hands-on training with current equipment provided by supplier partners and with up-to-date approaches to documentation and regulatory requirements. Many university- and…

August 10, 2018

Emergent: $270m PaxVax acquisition and Baltimore expansion boost CDMO biz

by

Emergent adds its first European biomanufacturing facility through the acquisition of vaccine maker PaxVax. Meanwhile in Baltimore, the firm has announced a $50 million fill/finish expansion. The US$270 million (€236 million) adds two vaccines approved by the US against cholera and typhoid fever to Emergent BioSolutions’ portfolio, along with several candidates including an Adenovirus 4/7 vaccine being developed for military personnel under contract with the US Department of Defense (DoD). The acquisition also brings Emergent its first biomanufacturing facility outside…

August 10, 2018